NDC11 67184053101
This exact 11-digit normalized identifier can correspond to more than one FDA hyphenation. FDA.report preserves the exact identifier and exposes every structurally valid candidate without guessing.
Possible FDA NDC forms#
| Package NDC | Product root |
|---|---|
| 67184-0531-01 | 67184-0531 |
| 67184-0531-1 | 67184-0531 |
| 67184-531-01 | 67184-531 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Gefitinib | GEFITINIB | Qilu Pharmaceutical Co., Ltd. | 0afc12dd-12f8-4def-9027-f38412a862b9 | 2023-02-22 | Warnings, Adverse reactions | 67184-0531-1 67184-0531 67184053101 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.